跳转至内容
Merck
所有图片(1)

Key Documents

PZ0196

Sigma-Aldrich

Tenidap

≥97% (HPLC)

别名:

(3Z)-5-Chloro-2,3-dihydro-3-(hydroxy-2-thienylmethylene)-2-oxo-1H-indole-1-carboxamide, CP 66248

登录查看公司和协议定价
所有图片(1)

About This Item

经验公式（希尔记法）:
C14H9ClN2O3S
CAS号:
120210-48-2
分子量:
320.75
分類程式碼代碼:
12352200
NACRES:
NA.77

品質等級

100

化驗

≥97% (HPLC)

形狀

powder

顏色

faintly yellow to dark yellow

溶解度

DMSO: 1 mg/mL, clear (warmed)

儲存溫度

2-8°C

InChI

1S/C14H9ClN2O3S/c15-7-3-4-9-8(6-7)11(13(19)17(9)14(16)20)12(18)10-2-1-5-21-10/h1-6,19H,(H2,16,20)

InChI 密鑰

IZSFDUMVCVVWKW-UHFFFAOYSA-N

生化／生理作用

Tenidap is an anti-inflammatory and anti-rheumatic with a variety of activities. Tenidap preferentially inhibits COX-1 with an IC50 value of 30 nM, and also has some lesser inhibitory activity towards COX-2 and 5-lipoxygenase (IC50 values are 1.2 and > 30 μM for COX-2 and 5-lipoxygenase respectively). Tenidap is also a cytokine modulator, an opener of inward rectifying hKIR2.3 channels (EC50 = 402 nM) and has been shown to modulate cytoplasmic pH and inhibit anion transport in vitro.

象形圖

Exclamation mark
GHS07

訊號詞

Warning

危險聲明

H302

危險分類

Acute Tox. 4 Oral

儲存類別代碼

11 - Combustible Solids

水污染物質分類（WGK）

WGK 3

閃點（°F）

Not applicable

閃點（°C）

Not applicable

分析证书(COA)

输入产品批号来搜索 分析证书(COA) 。批号可以在产品标签上"批“ （Lot或Batch）字后找到。

已有该产品？

在文件库中查找您最近购买产品的文档。

访问文档库

Tenidap.
R Madhok
Lancet (London, England), 346(8973), 481-485 (1995-08-19)
J C Fernandes et al.
The Journal of rheumatology, 25(5), 951-958 (1998-05-23)
To examine the effect of tenidap on the expression of collagenase- and interleukin 1beta (IL-1beta) genes in experimental canine osteoarthritis (OA). The anterior cruciate ligaments of the right stifle joints of experimental dogs were sectioned by a stab wound incision
X Ayral et al.
Osteoarthritis and cartilage, 11(3), 198-207 (2003-03-08)
To test the hypothesis that tenidap has a structure-modifying effect in human knee osteoarthritis. multicenter, prospective, randomized, double blind, 1 year duration. primary painful knee osteoarthritis (ACR criteria) of the medial tibiofemoral compartment, medial joint space width > or =2mm
Tenidap: not just another NSAID?
J M Canvin et al.
Annals of the rheumatic diseases, 55(2), 79-82 (1996-02-01)
S D Nelson
Advances in experimental medicine and biology, 500, 33-43 (2002-01-05)
This chapter provides just a few newer examples of structural moieties found in drugs that have been associated with reactive metabolite formation and toxicities. For a discussion of several other structures in drugs that undergo metabolic activation to reactive intermediates
查看所有相关文献

我们的科学家团队拥有各种研究领域经验，包括生命科学、材料科学、化学合成、色谱、分析及许多其他领域.

联系技术服务部门